Friday, May 20, 2011

New research on Migriane Medication focuses on Trigeminal Nerve

A recent article in Cephalgia (see abstract below) focuses on the kynurenine family of compounds which are metabolites of tryptophan in treating migraines. The use of Neuromuscular Dentistry uses neural input to correct chemical imbalances in the Trigeminal Nervous System to treat and eliminate migraines and chronic daily headaches.The use of drugs to alter neurotransmitters has been shown to be

No comments:

Post a Comment